BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19890696)

  • 1. Validation of the pepsinogen test method for gastric cancer screening using a follow-up study.
    Mizuno S; Kobayashi M; Tomita S; Miki I; Masuda A; Onoyama M; Habu Y; Inokuchi H; Watanabe Y
    Gastric Cancer; 2009; 12(3):158-63. PubMed ID: 19890696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Western long-term accuracy of serum pepsinogen-based gastric cancer screening.
    Castro C; Dinis-Ribeiro M; Rodrigues ANG; Calheiros T; Santos J; Pereira P; Ramos M; Cunha H; Andrade M; Costa A; Sá L; Antunes L; Bento MJ; Lomba-Viana R
    Eur J Gastroenterol Hepatol; 2018 Mar; 30(3):274-277. PubMed ID: 29215432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up study on a high risk population of gastric cancer in north China by serum pepsinogen assay.
    Sun LP; Gong YH; Wang L; Gong W; Yuan Y
    J Dig Dis; 2008 Feb; 9(1):20-6. PubMed ID: 18251790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population.
    Miki K; Fujishiro M; Kodashima S; Yahagi N
    Dig Endosc; 2009 Apr; 21(2):78-81. PubMed ID: 19691778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
    Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis].
    Chae H; Lee JH; Lim J; Kim M; Kim Y; Han K; Kang CS; Shim SI; Kim JI; Park SH
    Korean J Lab Med; 2008 Jun; 28(3):201-6. PubMed ID: 18594172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions.
    Shafaghi A; Mansour-Ghanaei F; Joukar F; Sharafkhah M; Mesbah A; Askari K; Geranmayeh S; Mehrvarz A; Souti F; Sokhanvar H; Fakhrieh S; Aminian K; Yousefi-Mashhour M; Khosh-Sorur M; Rasoulian J
    Asian Pac J Cancer Prev; 2013; 14(6):3931-6. PubMed ID: 23886209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum pepsinogen test for early detection of gastric cancer in a European country.
    Lomba-Viana R; Dinis-Ribeiro M; Fonseca F; Vieira AS; Bento MJ; Lomba-Viana H
    Eur J Gastroenterol Hepatol; 2012 Jan; 24(1):37-41. PubMed ID: 21989121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori: a 1-year follow-up study.
    Gisbert JP; Boixeda D; Al-Mostafa A; Vila T; de Rafael L; Alvarez Baleriola I; de Argila CM; Abraira V
    Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):189-200. PubMed ID: 10102232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography.
    Ohata H; Oka M; Yanaoka K; Shimizu Y; Mukoubayashi C; Mugitani K; Iwane M; Nakamura H; Tamai H; Arii K; Nakata H; Yoshimura N; Takeshita T; Miki K; Mohara O; Ichinose M
    Cancer Sci; 2005 Oct; 96(10):713-20. PubMed ID: 16232204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of gastric cancer screening using the serum pepsinogen test method.
    Miki K; Morita M; Sasajima M; Hoshina R; Kanda E; Urita Y
    Am J Gastroenterol; 2003 Apr; 98(4):735-9. PubMed ID: 12738449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Serum Pepsinogens and Helicobacter Pylori Infection with High-Sensitivity C-Reactive Protein in Medical Examination Population.
    Liu H; Fei C; Zhang J
    Lab Med; 2021 Jan; 52(1):57-63. PubMed ID: 32702129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer.
    Lee JY; Park KS; Lee HG; Baek WK; Cho KB; Lee YJ; Lee YS; Ryu SW
    Clin Exp Med; 2017 Aug; 17(3):403-410. PubMed ID: 27154568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk.
    Kaise M; Miwa J; Tashiro J; Ohmoto Y; Morimoto S; Kato M; Urashima M; Ikegami M; Tajiri H
    J Gastroenterol; 2011 Jun; 46(6):736-45. PubMed ID: 21455714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of gastric cancer biomarkers pepsinogen PGI/PGII using element tagged immunoassay coupled with inductively coupled plasma mass spectrometry detection.
    Jiang W; Sun G; Zhang Y; Hu Z; Wen X; Men S; Xing Z; Zhang S; Huang B; Wang C
    J Clin Lab Anal; 2020 Jul; 34(7):e23287. PubMed ID: 32147885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
    Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
    Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Pepsinogen Levels Are Correlated With Age, Sex and the Level of Helicobacter pylori Infection in Healthy Individuals.
    Huang RG; Xiao HL; Zhou B; Song XH; Zhang J; Wang CM; Jiang YH; Chen DZ; Huang B
    Am J Med Sci; 2016 Nov; 352(5):481-486. PubMed ID: 27865295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of MRI-DWI signal intensity value combined with serum PGI, PGII and CA199 in early gastric cancer.
    Li M; Zheng G; Yu L; Tan LL; Li X; Li MJ; Li C; Li S; Liang J; Zhong Z; Li ZM
    Cell Mol Biol (Noisy-le-grand); 2021 Aug; 67(2):95-100. PubMed ID: 34817333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastric carcinoma].
    Li YH; Zhang XH; Huang B; Wang JL; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Oct; 27(10):840-4. PubMed ID: 17343174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.